No Detail Found!

Comparative Acute Oral Toxicity Study of Verona AntiBPH with Verona Max in Mice.

Author(s)
Hina Rehman Faculty of Pharmacy, Jinnah Sindh Medical University, Karachi, Pakistan
Saira Bano Research & Development, Herbion Pakistan (Pvt.) Limited, Karachi, Pakistan
Faheem Akhtar Research & Development, Herbion Pakistan (Pvt.) Limited, Karachi, Pakistan
Saima Asif Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Aqib Zahoor Research & Development, Herbion Pakistan (Pvt.) Limited, Karachi, Pakistan
Kashifa Khanum Research & Development, Herbion Pakistan (Pvt.) Limited, Karachi, Pakistan
Safila Naveed Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Khan Usmanghani Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan; Research & Development, Herbion Pakistan (Pvt.) Limited, Karachi, Pakistan
Abstract
Objective: Benign Prostate hyperplasia (BPH) is hyperplasia of prostate gland and age related diseases in men. 20%-60% men have BPH with the age of 40 to 60 years. The cause is not very well researched however the pharmacological and surgical current treatments have numerous toxic effects on quality of life. Natural medicines are known for its safety as compare to pharmacological choice of medicines. By considering this fact, current experimental study was established to compare and assess the acute oral toxicity of the Verona Anti-PBH with Verona Max in NMRI strain of mice on animal model. Methodology: NMRI mice were obtained for experimental purpose from animal house facility of Herbion Pvt. Ltd. Constant environmental conditions were 25 ± 1 °C with R.H 52 - 61% with 12 hours dark and light cycle. As per desire, food and water were available. Animals were divided into three different groups including two treatment and control group. Treatment group including Verona Anti-BPH and Verona Max however control group were on water. Animal's age were 6-8 weeks and average body weight were 25-35 g however cage cards were used for identifications between the groups. Mice were treated orally using gastric gavage with doses (1 or 5g/kg) of test product for 14 days and observed daily. Results: The Verona anti-BPH and Verona Max did not cause any sign of ill health and acute toxicity in mice at the given doses of 1 or 5 g/kg. No hair loss, color loss, heart rate (chest expansion and retraction), writhing, stretching and fecal abnormality was observed. No remarkable change in the behavior and no mortality was observed. Conclusion: The present study evaluated that Verona anti-BPH and Verona Max extract is potentially safe and no acute oral toxicity has found.
Publication Details
Page(s) 259-263
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 6, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
verona, Benign Prostate Hyperplasia (BPH), herbal remedy, acute oral toxicity
References
RoehrbornCG, 2008.The utility of serum prostaticspecific antigen in the management of men with benign prostatic hyperplasia,Int J Impotence Res 20 S19 -
SafarinejadMR, 2008.Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older,Int Urol Nephrol 40 921 -31
RoehrbornCG, 2005.Benign prostatic hyperplasia: an overview,Rev Urol 7 S3 -
CoffeyD,WalshP., 1990.Clinical and experimental studies of benign prostatic hyperplasia,Urologic Clin N Am 17 461 -75
WilsonJD, 1980.The pathogenesis of benign prostatic hyperplasia,Am J Med 68 745 -56
ChatelainC,DenisL,FooK,KhouryS,McConnellJ, 2001.Benign prostatic hyperplasia. 5th consultation on benign prostatic hyperplasia (BPH, -
AbramsP,SchulmanCC,VaageS. Tamsulosin,, 1995.a selective α1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH),The European Tamsulosin Study Group. Br J Urol 76 325 -36
ChappleCR,WyndaeleJJ,NordlingJ,BoeminghausF,YpmaAF,AbramsP, .Tamsulosin, the first prostate-selective alpha 1Aadrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH), -
SouvereinP,ErkensJ,de la RosetteJ,LeufkensH,HeringsR., 2003.Drug treatment of benign prostatic hyperplasia and hospital admission for BPHrelated surgery,Eur Urol 43 528 -34
CanedyD., 1998.Real medicine or medicine show? Growth of herbal remedy sales raises issues about value, -
TylerVE. What,Pharmacists Should Kno\N About Herbal, 1996.Remedies: Pharmacists can help patients differentiate the useful herbs from the harmful ones,J Am Pharmaceut Assoc 36 29 -39
McClureMW, 2002.An overview of holistic medicine and complementary and alternative medicine for the prevention and treatment of BPH, prostatitis, and prostate cancer,World J Urol 20 273 -84
MarksLS,TylerVE, 1999.Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia,Urology 53 457 -61
WiltTJ,IshaniA,StarkG,MacDonaldR,LauJ,MulrowC, 1998.Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review,JAMA 280 1604 -9
GordonAE,ShaughnessyAF, 2003.Saw palmetto for prostate disorders,Am Fam Physician 67 1281 -3
WagnerH,WillerF,SamtlebenR,BoosG, 1994.Search for the antiprostatic principle of stinging nettle (Urtica dioica) roots,Phytomedicine 1 213 -24
2016.Review of Cucurbita pepo (pumpkin) its phytochemistry and pharmacology,Med Chem 6 012 -021
WiltT,IshaniA,Mac DonaldR,RutksI,StarkG, 2002.(1): CD001044.,Cochrane Database Syst Rev -
WertzK,SilerU,Goralczyk R. Lycopene, 2004.: modes of action to promote prostate health,Arch Biochem Biophys 430 127 -34
ZenicoT,CiceroA,ValmorriL,MercurialiM,BercovichE, 2009.Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial,Andrologia 41 95 -9
RehmanSU,ChoeK,YooHH, 2016.Review on a traditional herbal medicine, Eurycoma longifolia jack (Tongkat Ali): Its traditional uses, chemistry, evidence-based pharmacology and toxicology,Molecules 21 331 -
AlbersenM,OrabiH,LueTF, 2012.Evaluation and treatment of erectile dysfunction in the aging male: a mini-review,Gerontology 58 3 -14
SellandiTM,ThakarAB,BaghelMS, 2012.Clinical study of Tribulus terrestris Linn. in Oligozoospermia: A double blind study,Ayu 33 356 -64
McConnellJD,BarryMJ,BruskewitzRC, 1994.Benign prostatic hyperplasia: diagnosis and treatment,Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin (8 1 -17
IrwigMS, 2012.Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects,J Clin Psychiatry 73 1220 -3
0

Citations

0

Downloads

47

Views